product name
|
Levodopa
|
Cas number
|
59-92-7
|
Molecular formula
|
C9H11NO4
|
Molecular weight
|
197.19
|
Appearance
|
white powder
|
Brand
|
HBLV
|
Storage
|
cool dry place
|
Purity
|
99%
|
Package
|
1kg/bag 25kg/drum
|
EINECS
|
200-445-2
|
Fuction:
1, It is anti-paralysis agitans. Through the blood-brain barrier into the brain tissue, but by the decarboxylation of dopa decarboxylase into dopamine, play a role.
2, For essential tremor and paralysis paralysis agitans syndrome of non-drug immunogenicity, and in better light, severe, or the elderly poor.
3, Promote muscle growth,loss weight.
4, Increased bone density and reversal of osteoporosis.
5, Dietary supplements.
6, Treat parkinsonism and Pakinsonism syndrome, hepatic coma,hub functions to improve the patient awake, symptom improvement.
7, Promote sleep,improve immune system.
8, Weight loss.
9,Increase bone density and reversal of osteoporosis,increase muscle strength,enhance libido and sexual performance.
Application:
1, Pharmaceutical field.
2, Functional food field.
3, Health products field.
4, Personal care.
5, Nutritional supplements, used to adjust immunity.
Items |
Specifications |
Results |
Appearance |
White to off-white powder |
Off-white powder |
Solubility |
Slightly soluble in water,
practically insoluble in ethanol(96%).
Freely soluble in 1M hydrochloric acid
and sparingly soluble in 0.1M hydrochloric acid.
|
Conforms |
Identifycation |
Infrared absorption spectrum corresponds to the spectrum obtained with the RS. |
Conforms |
Appearance of solution |
The solution is not more intensely coloured than reference solution BY6 |
Conforms |
pH |
4.5~7.0 |
5.7 |
Loss on drying |
≤1.0% |
0.10% |
Sulfated ash |
≤0.1% |
0.10% |
Heavy metals |
≤10ppm |
Conforms |
Enantiomeric(HPLC) |
Impurity D≤0.5% |
N.D |
Related substances(HPLC) |
Impurity A≤0.1% |
0.02% |
Impurity B≤0.5% |
0.03% |
Impurity C≤0.2% |
N.D |
Any unspecified impurity≤0.05% |
0.02% |
Total Impurities≤1.0% |
0.10% |
Assay(Titration) |
99.0%~101.0%(Calculated on anhydrous basis) |
99.00% |
Conclusion |
Complies with European Pharmacopoeia standard |